Henry E. Pelish - 16 Dec 2024 Form 4 Insider Report for Nuvalent, Inc. (NUVL)

Role
Chief Scientific Officer
Signature
/s/ Nathan N. McConarty, attorney-in-fact
Issuer symbol
NUVL
Transactions as of
16 Dec 2024
Net transactions value
+$7,759
Form type
4
Filing time
18 Dec 2024, 16:50:49 UTC
Previous filing
18 Sep 2024
Next filing
08 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NUVL Class A Common Stock Options Exercise $3,844 +5,914 +18% $0.6500 39,214 16 Dec 2024 Direct
transaction NUVL Class A Common Stock Options Exercise $3,915 +4,500 +11% $0.8700 43,714 16 Dec 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NUVL Stock Option (Right to Buy) Options Exercise $0 -5,914 -100% $0.000000 0 16 Dec 2024 Class A Common Stock 5,914 $0.6500 Direct F1
transaction NUVL Stock Option (Right to Buy) Options Exercise $0 -4,500 -47% $0.000000 5,127 16 Dec 2024 Class A Common Stock 4,500 $0.8700 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option are fully vested.